Odonate Therapeutics, Inc. Operating Lease Liability
Odonate Therapeutics, Inc. had Operating Lease Liability of $4.85 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2021-11-10
- 2021-09-30: Operating Lease, Liability $4.85M.
- 2021-06-30: Operating Lease, Liability $5.03M.
- 2021-03-31: Operating Lease, Liability $5.20M.
- 2020-12-31: Operating Lease, Liability $5.33M.
| Period end | Operating Lease, Liability |
|---|---|
| 2021-09-30 | $4.85M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $5.03M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $5.20M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $5.33M 10-K · filed 2021-02-23 |
| 2020-09-30 | $5.38M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $1.91M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $1.98M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $2.06M 10-K · filed 2020-02-20 |
| 2019-09-30 | $2.24M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.41M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $2.58M 10-Q · filed 2019-04-25 |
| 2019-01-01 | $2.70M 10-K · filed 2020-02-20 |